Abstract
Disease-mongering in the case of sexual problems has some special elements. These include that discussions of sex provoke embarrassment and reveal a lack of knowledge on the part of both clinician and patient, the aggressiveness of Big Pharma in the face of the huge profitability of sexual products; and the socially constructed nature of sexual satisfaction. These special elements engender concern for the prospects for patient empowerment and the convergence of patient-clinician power in the consulting room. Consequently, political action to raise public and professional awareness about the realities of commercialisation and conflict of interest, and to resist further medicalisation may be as warranted for concerned scholars as academic analyses, at least at the present time.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Endnotes
Paver L, Disease-mongers: how doctors, drug companies, and insurers are making you feel sick, New York: John Wiley and Sons, 1992.
Moynihan R and Cassels A, Selling Sickness: how the world’s biggest pharmaceutical companies are turning us all into patients, New York: Nation Books, 2005; Kassirer J, On the Take: how medicine’s complicity with big business can endanger your health. New York: Oxford Universitv Press, 2005; Abramson J, Overdosed America: the broken promise of American medicine, New York: Harpercollins, 2004; Angell M, The Truth about Drug Companies: how they deceive us and what to do about it, New York: Random House, 2005; Critser G, Generation Rx: how prescription drugs are altering American lives, minds, and bodies, Boston: Houghton-Mifflin, 2005; Avorn J, Powerful Medicines: the benefits, risks and costs of prescription drugs, New York: Alfred A. Knopf, 2004.
Tiefer L, ‘In pursuit of the perfect penis: the medicalization of male sexuality’, Americon Behavioral Scientist, vol. 29, 1986, pp. 579–599; Tiefer L, ‘The Medicalization of impotence: normalizing phallocentrism’, Gender and Society, vol. 8, 1994, pp. 363–377; Tiefer L, ‘Resisting medicalization requires more than balance’, Journal of Sex Education and Therapy, vol. 21, 1995, pp. 62–63; Tiefer L, ‘The medicalization of sexuality: conceptual, normative, and professional issues’, Annual Reuiew of Sex Research, vol. 7, 1996, pp. 252–282; Tiefer L, ‘Doing the Viagra tango: sex pill as symbol and substance’, Radical Philosophy, no. 92, 1998, pp. 2–5; Tiefer L, ‘The selling of “female sexual dysfunction”’, Journal of Sex and Marital Therapy, vol. 27, 2001, pp. 625–628; Tiefer L, The “Consensus” conference on female sexual dysfunction: conflicts of interest and hidden agendas’, Journal of Sex and Marital Therapy, vol. 27, 2001, pp. 227–236; Tiefer L, ‘The pink Viagra story’, Radical Philosophy, no. 121, 2003, pp. 2–5; Tiefer L, Sex is Not a Natural Act, and other essays, 2nd ed. (1st ed. 1995) Boulder: CO, Westview Press, 2004; Tiefer L, ‘Female Sexual Dysfunction: a case study of disease mongering and activist resistance’, Public Library of Science Medicine, vol. 3, no. 4, 2006, pp. 436–440.
Rubin R, ‘Communication about sexual problems in male patients with multiple sclerosis’, Nursing Standards, vol. 19, 2005, pp. 33–37.
Evans DT, ‘Speaking of sex: the need to dispel myths and overcome fears’, British Journal of Nursing, vol. 9, 2000, p. 659.
Scott J, ‘Children ask the damnedest questions!’: sexuality education as a social problem’, in Hawkes G and Scott J (eds), Perspectiues in Human Sexuality, Melbourne, Oxford University Press, 2005, pp. 168–186.
Meredith P, Sex Education: political issues in Britain and Europe, London: Routledge, 1989; Irvine JM, Talk about Sex: the battles over sex education in the United States, Berkeley: University of California Press, 2002.
Tiefer L, ‘The Viagra phenomenon’, Sexualities, vol. 9, 2006, pp. 273–294.
Tiefer, Sex is Not a Natural Act, op. cit., pp. 74–76.
Schlosser E, Reefer Madness: sex, drugs and cheap labor in the American black market, New York: Houghton Mifflin Company, 2003.
Seaman B, The Greatest Experiment Ever Performed on Women: exploding the estrogen myth, New York: Hyperion, 2003.
Loe M, The Rise of Viagra: how the little blue pill changed sex in America, New York: New York University Press, 2004.
An intraurethral pellet to treat erection problems was approved in November, 1996, but unpleasant side effects limited its popularity and it had the bad luck to precede the Direct-To-Consumer-Advertising (DTCA) era.
Luciano L, Looking Good: male body image in modern America, New York: Hill & Wang, 2001, p. 200.
By the Food and Dugs Administration Modernization Act of 1997
Baglia J, The Viagra AdVenture: masculinity, media and the performance of sexual health, New York: Peter Lang Publishing, 2005.
Elliott C, Better than Well: American medicine meets the American dream, New York, WW Norton, 2003.
Tiefer, Sex is Not a Natural Act, op. cit., pp. 15–67.
Parker RG and Gagnon JH, Conceiving Sexuality: approaches to sex research in a postmodern world, New York, Routledge, 1995; Weeks J, Holland J and Waites M, Sexualities and Society: a reader, Cambridge: Polity Press, 2003; Connell RW and Dowsett GW, Rethinking Sex: social theory and sexuality research, Melbourne: Melbourne University Press, 1992.
Tiefer L, Sex is Not a Natural Act, and other essays, 2nd ed. (1st ed. 1995), Boulder, CO, Westview Press, 2004, pp 5–14.
Tiefer, Sex is Not a Natural Act, op. cit., pp. 247–279; Tiefer Land Kaschak E (eds), A New View of Women’s Sexual Problems, Binghamton, New York: Haworth Press: see http://www.fsd-alert.org, the website of the New View Campaign for Women’s Sexual Problems.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tiefer, L. Sex and disease-mongering: a special case?. Monash Bioethics Review 25, 28–35 (2006). https://doi.org/10.1007/BF03549812
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03549812